Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
Ceribell, a medical technology company specializing in neurological diagnostics, has announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference. The company's CEO and Co-founder, Jane Chao, Ph.D., will deliver a presentation on Wednesday, May 14, 2025, at 10:55 AM PST (1:55 PM EST).
The presentation will be accessible to interested parties through a live webcast, which will also be archived for future reference. Viewers can access the webcast through the Investor Relations section of Ceribell's website at investors.ceribell.com.
Ceribell (Nasdaq: CBLL) focuses on transforming the diagnosis and management of serious neurological conditions through innovative medical technology solutions.
Ceribell, un'azienda di tecnologia medica specializzata in diagnostica neurologica, ha annunciato la sua partecipazione alla prossima Bank of America Securities 2025 Health Care Conference. La CEO e cofondatrice dell'azienda, Jane Chao, Ph.D., terrà una presentazione mercoledì 14 maggio 2025 alle 10:55 PST (13:55 EST).
La presentazione sarà disponibile per gli interessati tramite un webcast in diretta, che sarà anche archiviato per consultazioni future. Gli spettatori potranno accedere al webcast nella sezione Investor Relations del sito web di Ceribell all'indirizzo investors.ceribell.com.
Ceribell (Nasdaq: CBLL) si dedica a rivoluzionare la diagnosi e la gestione delle patologie neurologiche gravi attraverso soluzioni tecnologiche mediche innovative.
Ceribell, una empresa de tecnología médica especializada en diagnóstico neurológico, ha anunciado su participación en la próxima Bank of America Securities 2025 Health Care Conference. La CEO y cofundadora de la compañía, Jane Chao, Ph.D., realizará una presentación el miércoles 14 de mayo de 2025 a las 10:55 AM PST (1:55 PM EST).
La presentación estará disponible para interesados mediante una transmisión en vivo, que también quedará archivada para futuras consultas. Los espectadores podrán acceder a la transmisión a través de la sección de Relaciones con Inversionistas en el sitio web de Ceribell en investors.ceribell.com.
Ceribell (Nasdaq: CBLL) se enfoca en transformar el diagnóstico y manejo de condiciones neurológicas graves mediante soluciones innovadoras de tecnología médica.
Ceribell은 신경학적 진단에 특화된 의료 기술 회사로, 다가오는 Bank of America Securities 2025 Health Care Conference에 참여한다고 발표했습니다. 회사의 CEO 겸 공동 창립자인 Jane Chao 박사가 2025년 5월 14일 수요일 오전 10시 55분 PST(오후 1시 55분 EST)에 발표를 진행할 예정입니다.
발표는 관심 있는 분들을 위해 생중계 웹캐스트로 제공되며, 이후 다시 볼 수 있도록 기록도 보관됩니다. 시청자는 Ceribell 웹사이트의 투자자 관계 섹션인 investors.ceribell.com에서 웹캐스트에 접속할 수 있습니다.
Ceribell (나스닥: CBLL)은 혁신적인 의료 기술 솔루션을 통해 심각한 신경학적 질환의 진단 및 관리를 혁신하는 데 주력하고 있습니다.
Ceribell, une entreprise de technologie médicale spécialisée dans le diagnostic neurologique, a annoncé sa participation à la prochaine Bank of America Securities 2025 Health Care Conference. La PDG et cofondatrice de la société, Jane Chao, Ph.D., donnera une présentation le mercredi 14 mai 2025 à 10h55 PST (13h55 EST).
La présentation sera accessible aux intéressés via une webdiffusion en direct, qui sera également archivée pour consultation ultérieure. Les spectateurs pourront accéder à la webdiffusion via la section Relations Investisseurs du site web de Ceribell à l'adresse investors.ceribell.com.
Ceribell (Nasdaq : CBLL) se concentre sur la transformation du diagnostic et de la gestion des affections neurologiques graves grâce à des solutions innovantes en technologie médicale.
Ceribell, ein Medizintechnikunternehmen, das sich auf neurologische Diagnostik spezialisiert hat, hat seine Teilnahme an der bevorstehenden Bank of America Securities 2025 Health Care Conference angekündigt. Die CEO und Mitgründerin des Unternehmens, Jane Chao, Ph.D., wird am Mittwoch, den 14. Mai 2025, um 10:55 Uhr PST (13:55 Uhr EST) eine Präsentation halten.
Die Präsentation wird für Interessierte über einen Live-Webcast zugänglich sein, der auch für die spätere Ansicht archiviert wird. Zuschauer können den Webcast über den Bereich Investor Relations auf der Ceribell-Website unter investors.ceribell.com abrufen.
Ceribell (Nasdaq: CBLL) konzentriert sich darauf, die Diagnose und Behandlung schwerer neurologischer Erkrankungen durch innovative Medizintechniklösungen zu revolutionieren.
- CEO presentation at a major healthcare investment conference indicates strong institutional visibility
- None.
SUNNYVALE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming Bank of America Securities 2025 Health Care Conference. The presentation will take place on Wednesday, May 14, 2025, at 10:55 a.m. Pacific Standard Time / 1:55 p.m. Eastern Standard Time.
Event: Bank of America Securities 2025 Health Care Conference
Date: Wednesday, May 14, 2025
Time: 10:55 a.m. PST / 1:55p.m. EST
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com
Media Contact
Corrie Rose
Press@ceribell.com
FAQ
When will Ceribell (CBLL) present at the Bank of America Healthcare Conference 2025?
How can investors watch Ceribell's (CBLL) presentation at the BofA Healthcare Conference?
What is Ceribell's (CBLL) focus in the medical technology sector?
Who will represent Ceribell (CBLL) at the 2025 BofA Healthcare Conference?
Where will the Bank of America Healthcare Conference featuring Ceribell (CBLL) be held?
